1. Home
  2. HOLX

as 12-18-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Electronics

Nasdaq

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Founded: 1985 Country:
United States
United States
Employees: N/A City: MARLBOROUGH
Market Cap: 18.3B IPO Year: 1990
Target Price: $89.50 AVG Volume (30 days): 2.1M
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 3.32 EPS Growth: 81.42
52 Week Low/High: $70.24 - $84.67 Next Earning Date: 01-30-2025
Revenue: $4,030,300,000 Revenue Growth: -0.00%
Revenue Growth (this year): 1.73% Revenue Growth (next year): 4.07%

HOLX Daily Stock ML Predictions

Stock Insider Trading Activity of Hologic Inc. (HOLX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Mitchell Essex D HOLX Chief Operating Officer Dec 4 '24 Sell $76.34 24,856 $1,897,482.18 27,957

Share on Social Networks: